首页> 美国政府科技报告 >Generic Cost Estimates: Abstracts from Generic Studies for Use in Preparing Regulatory Impact Analyses.

【24h】

Generic Cost Estimates: Abstracts from Generic Studies for Use in Preparing Regulatory Impact Analyses.

机译：通用成本估算：通用研究摘要用于准备法规影响分析。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 1986
页码 1-158
总页数 158
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Nuclear power plants; Regulations; Cost estimates; Modifications;

机译：核电厂;法规;成本估算;修改;

相似文献

外文文献
中文文献
专利

1. Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug [J] . Jason R Guertin, Dominic Mitchell, Farzad Ali, ClinicoEconomics and Outcomes Research . 2015,第2期

机译：经济评估中的偏见–考虑未来使用低成本仿制药对新药目前估计的增量成本效益比的影响
2. Regulatory Solutions to the Problem of High Generic Drug Costs [J] . Aaron S. Kesselheim, Ameet Sarpatwari, Jing Luo Open Forum Infectious Diseases . 2015,第4期

机译：高仿制药成本问题的监管解决方案
3. Biosimilars: Still Seeking a Door to the MarketBiosimilar medicines are now an established part of the EU regulatory scene, but they have yet to make an impact on the market, and elsewhere progress towards a regulatory framework is slow. Ian Schofield reports from the European Generic medicines Association's latest biosimilars conference. [J] . neena brizmohun The regulatory affairs journal: Pharma . 2008,第6期

机译：生物仿制药：仍在寻求进入市场的机会生物仿制药已经成为欧盟监管领域的既定组成部分，但尚未对市场产生影响，在其他方面，监管框架的进展缓慢。伊恩·斯科菲尔德（Ian Schofield）来自欧洲仿制药协会最新的生物仿制药会议的报告。
4. Estimating the Cost of Generic Quantum Pre-image Attacks on SHA-2 and SHA-3 [C] . Matthew Amy, Olivia Di Matteo, Vlad Gheorghiu, International conference on selected areas in cryptography . 2017

机译：估算对SHA-2和SHA-3进行通用量子图像前攻击的成本
5. Study on impacts of promotion of generic drug utilization on spontaneous adverse event reports and drug safety assessment at the post-market stage [D] . TAKAMI, Akina 2019

机译：上市后阶段推广仿制药利用对自发不良事件报告和药物安全评估的影响
6. Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug [O] . Jason R Guertin, Dominic Mitchell, Farzad Ali, 2015

机译：经济评估中的偏见–考虑将来使用低成本仿制药对新药目前估计的增量成本效益比的影响
7. PCV26 Pharmacoepidemiological Study of HMG CoA Reductase Inhibitor Prescribing: Impact of Generic Prescribing on Cost [O] . Truter I. 2013

机译：HMG CoA还原酶抑制剂处方的PCV26药物流行病学研究：通用处方对费用的影响
8. Generic Cost Estimates: Abstracts from Generic Studies for Use in Preparing Regulatory Impact Analyses. [R] . Claiborne, E., Sciacca, F., Simion, G., 1989

机译：通用成本估算：通用研究摘要用于准备法规影响分析。

Generic Cost Estimates: Abstracts from Generic Studies for Use in Preparing Regulatory Impact Analyses.

著录项

引文网络

相似文献

相关主题

期刊订阅